BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Maria Graziella Catalano, Mariateresa Pugliese, Eleonora Gargantini, Cristina Grange, Benedetta Bussolati, Sofia Asioli, Ornella Bosco, Roberta Poli, Alessandra Compagnone, Andrea Bandino, Franco Mainini, Nicoletta Fortunati, Giuseppe Boccuzzi. Cytotoxic activity of the histone deacetylase inhibitor panobinostat (LBH589) in anaplastic thyroid cancer in vitro and in vivoInternational Journal of Cancer 2012; 130(3): 694 doi: 10.1002/ijc.26057
2
Yudibeth Sixto-López, Martiniano Bello, José Correa-Basurto. Insights into structural features of HDAC1 and its selectivity inhibition elucidated by Molecular dynamic simulation and Molecular DockingJournal of Biomolecular Structure and Dynamics 2019; 37(3): 584 doi: 10.1080/07391102.2018.1441072
3
Dmitriy I Dovzhanskiy, Stefanie M Arnold, Thilo Hackert, Ina Oehme, Olaf Witt, Klaus Felix, Nathalia Giese, Jens Werner. Experimental in vivo and in vitro treatment with a new histone deacetylase inhibitor belinostat inhibits the growth of pancreatic cancerBMC Cancer 2012; 12(1) doi: 10.1186/1471-2407-12-226
4
Lubna Wasim, Madhu Chopra. Panobinostat induces apoptosis via production of reactive oxygen species and synergizes with topoisomerase inhibitors in cervical cancer cellsBiomedicine & Pharmacotherapy 2016; 84: 1393 doi: 10.1016/j.biopha.2016.10.057
5
Elisabeth Hessmann, Steven A Johnsen, Jens T Siveke, Volker Ellenrieder. Epigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?Gut 2017; 66(1): 168 doi: 10.1136/gutjnl-2016-312539
6
Günter Schneider, Oliver H. Krämer, Petra Fritsche, Susanne Schüler, Roland M. Schmid, Dieter Saur. Targeting histone deacetylases in pancreatic ductal adenocarcinomaJournal of Cellular and Molecular Medicine 2010; 14(6a): 1255 doi: 10.1111/j.1582-4934.2009.00974.x
7
Ouaïssi Mehdi, Silvy Françoise, Costa Lima Sofia, Giger Urs, Zemmour Kevin, Sastre Bernard, Sielezneff Igor, Cordeiro-da-Silva Anabela, Lombardo Dominique, Mas Eric, Ouaïssi Ali. HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA)Pancreatology 2012; 12(2): 146 doi: 10.1016/j.pan.2012.02.013
8
Weiqiang Zhou, I-Chau Liang, Nelson S. Yee. Histone deacetylase 1 is required for exocrine pancreatic epithelial proliferation in development and cancerCancer Biology & Therapy 2011; 11(7): 659 doi: 10.4161/cbt.11.7.14720
9
Georg Feldmann, Anirban Maitra. Drug Discovery in Pancreatic Cancer2010; : 181 doi: 10.1007/978-1-4419-1160-5_10
10
Avineesh Singh, Vijay K. Patel, Deepak K. Jain, Preeti Patel, Harish Rajak. Panobinostat as Pan-deacetylase Inhibitor for the Treatment of Pancreatic Cancer: Recent Progress and Future ProspectsOncology and Therapy 2016; 4(1): 73 doi: 10.1007/s40487-016-0023-1
11
Nikolaos Garmpis, Christos Damaskos, Anna Garmpi, Serena Valsami, Dimitrios Dimitroulis. Pharmacoepigenetics2019; : 501 doi: 10.1016/B978-0-12-813939-4.00013-9
12
Yi Zou, Gillian M. Howell, Lisa E. Humphrey, Jing Wang, Michael G. Brattain, Lu-Zhe Sun. Ron Knockdown and Ron Monoclonal Antibody IMC-RON8 Sensitize Pancreatic Cancer to Histone Deacetylase Inhibitors (HDACi)PLoS ONE 2013; 8(7): e69992 doi: 10.1371/journal.pone.0069992
13
Qi Xie, Lin Jia, Yan-Hong Liu, Cheng-Gang Wei. Synergetic anticancer effect of combined gemcitabine and photodynamic therapy on pancreatic cancer <italic>in vivo</italic>World Journal of Gastroenterology 2009; 15(6): 737-741 doi: 10.3748/wjg.15.737
14
Paola Neri, Nizar J Bahlis, Sagar Lonial. Panobinostat for the treatment of multiple myelomaExpert Opinion on Investigational Drugs 2012; 21(5): 733 doi: 10.1517/13543784.2012.668883
15
Jasmijn G.M. van Kampen, Monica A.J. Marijnissen-van Zanten, Femke Simmer, Winette T.A. van der Graaf, Marjolijn J.L. Ligtenberg, Iris D. Nagtegaal. Epigenetic targeting in pancreatic cancerCancer Treatment Reviews 2014; 40(5): 656 doi: 10.1016/j.ctrv.2013.12.002
16
Antonino Grassadonia, Pasquale Cioffi, Felice Simiele, Laura Iezzi, Marinella Zilli, Clara Natoli. Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid MalignanciesCancers 2013; 5(4): 919 doi: 10.3390/cancers5030919
17
Dennis R. Grayson, Marija Kundakovic, Rajiv P. Sharma. Is There a Future for Histone Deacetylase Inhibitors in the Pharmacotherapy of Psychiatric Disorders?Molecular Pharmacology 2010; 77(2): 126 doi: 10.1124/mol.109.061333